Critique of the Canadian Multicenter Placebo-Controlled Study of Risperidone and Haloperidol.
Musser
W S
WS
Kirisci
L
L
D002170:Canada; D004311:Double-Blind Method; D006220:Haloperidol / Q000627:therapeutic use*; D006801:Humans; D007555:Isoxazoles / Q000627:therapeutic use*; D010880:Piperidines / Q000627:therapeutic use*; D012107:Research Design; D018967:Risperidone; D012559:Schizophrenia / Q000188:drug therapy*
D007555:Isoxazoles; D010880:Piperidines; D006220:Haloperidol; D018967:Risperidone